# Great Elm Capital Corp.: financial statements, quarterly

GECC · Nasdaq · CIK 1675033 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gecc.md) · [Financials](/companies/gecc/financials.md) · [Filings](/companies/gecc/filings.md) · [Insiders](/companies/gecc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gecc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net income | $m | [7.8](/filings/0000950170-24-119231.md) | [4.2 d](/filings/0001193125-26-085697.md) | [(0.5)](/filings/0000950170-25-063636.md) | [(1.3)](/filings/0000950170-25-102075.md) | [3.5](/filings/0001193125-25-264873.md) | [1.9 d](/filings/0001193125-26-085697.md) | [0.5](/filings/0001193125-26-204228.md) | [11.7](/filings/0001193125-26-335023.md) | [(22.0)](/filings/0001193125-25-264873.md) | [(22.0) d](/filings/0001193125-26-085697.md) | [(0.7)](/filings/0001193125-26-204228.md) | [6.4](/filings/0001193125-26-335023.md) |
| Diluted EPS | $ per share | [1.02](/filings/0000950170-24-119231.md) | not reported | [(0.05)](/filings/0000950170-25-063636.md) | [(0.14)](/filings/0000950170-25-102075.md) | [0.33](/filings/0001193125-25-264873.md) | not reported | [0.04](/filings/0001193125-26-204228.md) | [1.02](/filings/0001193125-26-335023.md) | [(1.79)](/filings/0001193125-25-264873.md) | not reported | [(0.05)](/filings/0001193125-26-204228.md) | [0.46](/filings/0001193125-26-335023.md) |
| Basic EPS | $ per share | [1.02](/filings/0000950170-24-119231.md) | not reported | [(0.05)](/filings/0000950170-25-063636.md) | [(0.14)](/filings/0000950170-25-102075.md) | [0.33](/filings/0001193125-25-264873.md) | not reported | [0.04](/filings/0001193125-26-204228.md) | [1.02](/filings/0001193125-26-335023.md) | [(1.79)](/filings/0001193125-25-264873.md) | not reported | [(0.05)](/filings/0001193125-26-204228.md) | [0.46](/filings/0001193125-26-335023.md) |

- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.8](/filings/0000950170-24-119231.md) | [1.0](/filings/0000950170-25-036517.md) | [0.3](/filings/0000950170-24-052100.md) | [2.6](/filings/0000950170-24-089240.md) | [0.3](/filings/0000950170-24-119231.md) | [0.0](/filings/0000950170-25-102075.md) | [1.3](/filings/0000950170-25-063636.md) | [1.0](/filings/0000950170-25-102075.md) | not reported | [1.8](/filings/0001193125-26-335023.md) | not reported | [1.7](/filings/0001193125-26-335023.md) |
| Total assets | $m | [246](/filings/0000950170-23-057727.md) | [247](/filings/0000950170-25-036517.md) | [279](/filings/0000950170-24-052100.md) | [327](/filings/0000950170-24-089240.md) | [427](/filings/0000950170-24-119231.md) | [342](/filings/0001193125-26-085697.md) | [351](/filings/0000950170-25-063636.md) | [409](/filings/0000950170-25-102075.md) | [420](/filings/0001193125-25-264873.md) | [341](/filings/0001193125-26-335023.md) | [283](/filings/0001193125-26-204228.md) | [280](/filings/0001193125-26-335023.md) |
| Total liabilities | $m | [148](/filings/0000950170-23-057727.md) | [148](/filings/0000950170-25-036517.md) | [160](/filings/0000950170-24-052100.md) | [201](/filings/0000950170-24-089240.md) | [301](/filings/0000950170-24-119231.md) | [206](/filings/0001193125-26-085697.md) | [219](/filings/0000950170-25-063636.md) | [269](/filings/0000950170-25-102075.md) | [280](/filings/0001193125-25-264873.md) | [228](/filings/0001193125-26-335023.md) | [175](/filings/0001193125-26-204228.md) | [170](/filings/0001193125-26-335023.md) |
| Shareholders' equity | $m | [97.9](/filings/0000950170-23-057727.md) | [98.7](/filings/0000950170-25-036517.md) | [119](/filings/0000950170-24-052100.md) | [126](/filings/0000950170-24-089240.md) | [126](/filings/0000950170-24-119231.md) | [136](/filings/0001193125-26-085697.md) | [132](/filings/0000950170-25-063636.md) | [140](/filings/0001193125-26-335023.md) | [140](/filings/0001193125-25-264873.md) | [113](/filings/0001193125-26-335023.md) | [107](/filings/0001193125-26-204228.md) | [110](/filings/0001193125-26-335023.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [10.5 d](/filings/0000950170-24-119231.md) | [2.1 d](/filings/0001193125-26-085697.md) | [(25.4)](/filings/0000950170-25-063636.md) | [(34.3) d](/filings/0000950170-25-102075.md) | [(54.4) d](/filings/0001193125-25-264873.md) | [31.4 d](/filings/0001193125-26-085697.md) | [(5.9)](/filings/0001193125-26-204228.md) | [9.7 d](/filings/0001193125-26-335023.md) | [(25.2) d](/filings/0001193125-25-264873.md) | [18.6 d](/filings/0001193125-26-085697.md) | [23.5](/filings/0001193125-26-204228.md) | [13.2 d](/filings/0001193125-26-335023.md) |
| Dividends paid | $m | [2.7 d](/filings/0000950170-24-119231.md) | [2.7 d](/filings/0001193125-26-085697.md) | [4.1](/filings/0000950170-25-063636.md) | [3.3 d](/filings/0000950170-25-102075.md) | [3.7 d](/filings/0001193125-25-264873.md) | [4.0 d](/filings/0001193125-26-085697.md) | [4.8](/filings/0001193125-26-204228.md) | [4.3 d](/filings/0001193125-26-335023.md) | [4.9 d](/filings/0001193125-25-264873.md) | [5.2 d](/filings/0001193125-26-085697.md) | [4.2](/filings/0001193125-26-204228.md) | [3.5 d](/filings/0001193125-26-335023.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q3 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [7.6](/filings/0000950170-23-057727.md) | [7.6](/filings/0000950170-24-052100.md) | [7.6](/filings/0000950170-24-089240.md) | [7.6](/filings/0000950170-24-119231.md) | [8.7](/filings/0000950170-25-063636.md) | [9.6](/filings/0000950170-25-102075.md) | [10.4](/filings/0001193125-25-264873.md) | [11.5](/filings/0001193125-26-204228.md) | [11.6](/filings/0001193125-26-335023.md) | [12.3](/filings/0001193125-25-264873.md) | [14.0](/filings/0001193125-26-204228.md) | [13.9](/filings/0001193125-26-335023.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 13,889,750 at 2026-07-29, from the cover of the [10-Q filed 2026-08-05](/filings/0001193125-26-335023.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.